http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111763157-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
filingDate 2020-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111763157-B
titleOfInvention Chiral amino compound, preparation method and application thereof, and preparation method for preparing edoxaban intermediate from chiral amino compound
abstract The invention provides a chiral amino compound, a preparation method and application thereof, and a preparation method for preparing an edoxaban intermediate from the chiral amino compound. The structure of the chiral amino compound is shown as a formula (III); the structure of the edoxaban intermediate prepared by the formula (III) is shown in the formula (I); wherein R is 1 And R 2 Independently a nitrogen protecting group or hydrogen; r is C 1~6 Alkoxy, N-dimethylamino, N-methylamino or benzylamino. The compound of the formula (III) can be prepared in a large scale and with high optical purity by only one-step reaction, a chiral resolution process is not needed, the preparation process is simple and efficient, and the cost is low; the compound of formula (III) is used as a raw material, and the edoxaban intermediate of formula (I) can be prepared through one-step reaction, expensive (S) -3-cyclohexene-1-formic acid is not needed as an initial raw material, chiral resolution is not needed, the route is short, the use of sodium azide can be effectively avoided, the reaction conditions are mild, the yield is high, and the method is suitable for large-scale industrial production.
priorityDate 2020-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7128364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10280735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419642367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17842493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11085761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414888040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426133545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454567036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421146596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44610678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414813063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451936144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456029861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419656506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9898815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408599808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414806636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641

Total number of triples: 78.